Tommy Eriksson
- Hematology top 2%
- Molecular Biology
- Oncology
- Spectroscopy top 10%
- Pharmacology top 5%
- Co-authors
- Sven BjörkmanPeter HöglundBodil RothHenrik EkbergIngemar TuressonAnders WaageHenrik BjörkBurl R. Don
- Topics
- Multiple Myeloma Research and Treatments (10 papers)Berberine and alkaloids research (5 papers)Cancer therapeutics and mechanisms (4 papers)
- Cited by
- HematologyPharmacologySpectroscopy
- Journals
- Plastic & Reconstructive SurgeryBritish Journal of HaematologyJournal of Pharmacy and Pharmacology
- Partner nations
- SwedenUnited StatesNorway
In The Last Decade
Tommy Eriksson
15 papers receiving 789 citations
Peers
Comparison fields: 5 of 101
- Hematology 391
- Molecular Biology 381
- Oncology 196
- Spectroscopy 138
- Pharmacology 88
Countries citing papers authored by Tommy Eriksson
This map shows the geographic impact of Tommy Eriksson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tommy Eriksson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tommy Eriksson more than expected).
Fields of papers citing papers by Tommy Eriksson
This network shows the impact of papers produced by Tommy Eriksson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tommy Eriksson. The network helps show where Tommy Eriksson may publish in the future.
Co-authorship network of co-authors of Tommy Eriksson
This figure shows the co-authorship network connecting the top 25 collaborators of Tommy Eriksson. A scholar is included among the top collaborators of Tommy Eriksson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tommy Eriksson. Tommy Eriksson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 24 | |
| 2 | 29 | |
| 3 | 60 | |
| 4 | Thalidomide inhibits early atherogenesis in apoE-deficient mice. | 11 |
| 5 | 221 | |
| 6 | 75 | |
| 7 | 2 | |
| 8 | 35 | |
| 9 | 44 | |
| 10 | 52 | |
| 11 | 16 | |
| 12 | 178 | |
| 13 | 53 | |
| 14 | Thalidomide prolongs graft survival in rat cardiac transplants. | 6 |
| 15 | High-performance liquid chromatography of vitamin E. | 9 |
About Tommy Eriksson
Tommy Eriksson is a scholar working on Hematology, Pharmacology and Computational Theory and Mathematics, having authored 15 papers that have together received 815 indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (10 papers), Berberine and alkaloids research (5 papers) and Cancer therapeutics and mechanisms (4 papers). The work is most often cited by research in Hematology (391 citations), Pharmacology (88 citations) and Spectroscopy (138 citations). Tommy Eriksson has collaborated with scholars based in Sweden, United States and Norway. Frequent co-authors include Sven Björkman, Peter Höglund, Bodil Roth, Henrik Ekberg, Ingemar Turesson, Anders Waage, Henrik Björk, Burl R. Don, George A. Kaysen and Corey S. Maas. Their work appears in journals such as Plastic & Reconstructive Surgery, British Journal of Haematology and Journal of Pharmacy and Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.